HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumonisin B1-induced increases in neurotransmitter metabolite levels in different brain regions of BALB/c mice.

Abstract
Fumonisin B1, a toxin produced by Fusarium moniliforme, causes a variety of diseases in animals, including those involving the central nervous system, such as equine leukoencephalomalacia (ELEM). The changes of biogenic amines may reflect fumonisin B1 neurotoxicity. It was previously reported that consumption of feed contaminated with Fusarium moniliforme cultures produced an elevation of 5-hydroxyindoleacetic acid (5-HIAA), the major metabolite of 5-hydroxytryptamine (5-HT), in whole rat brains. In a subsequent study from the same laboratory, rats given fumonisin B1 orally for 4 weeks showed no changes in neurotransmitter levels of the whole brain. In the current study, groups of five male BALB/c mice were injected with fumonisin B1 subcutaneously at doses of 0, 0.25, 0.75, 2.25, 6.75 mg kg-1 body weight daily for 5 days. One day after the last treatment, their brains were dissected into cerebrum, cerebellum, medulla oblongata, midbrain, corpus striatum and hypothalamus. Levels of norepinephrine (NE), dopamine (DA), DA metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and 5-HT and 5-HIAA were determined. A significant elevation of HVA was observed in mice treated with high doses of fumonisin B1 in most brain regions. In striatum, a decrease of 5-HT was observed by the fumonisin B1 treatment. Ratios of neurotransmitters to metabolites such as HVA/DA and 5-HIAA/5-HT were elevated in several brain regions of the treated groups. An accumulation of neurotransmitter metabolites is suggestive of increased neuronal activity or interference with their efflux from cells.
AuthorsM Tsunoda, R R Dugyala, R P Sharma
JournalComparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology (Comp Biochem Physiol C Pharmacol Toxicol Endocrinol) Vol. 120 Issue 3 Pg. 457-65 (Oct 1998) ISSN: 1367-8280 [Print] United States
PMID9827064 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carboxylic Acids
  • Carcinogens, Environmental
  • Fumonisins
  • Neurotransmitter Agents
  • 3,4-Dihydroxyphenylacetic Acid
  • Serotonin
  • fumonisin B1
  • Hydroxyindoleacetic Acid
  • Dopamine
  • Norepinephrine
  • Homovanillic Acid
Topics
  • 3,4-Dihydroxyphenylacetic Acid (metabolism)
  • Animals
  • Brain (drug effects, metabolism)
  • Brain Chemistry
  • Carboxylic Acids (administration & dosage, toxicity)
  • Carcinogens, Environmental (administration & dosage, toxicity)
  • Dopamine (metabolism)
  • Fumonisins
  • Homovanillic Acid (metabolism)
  • Hydroxyindoleacetic Acid (metabolism)
  • Injections, Subcutaneous
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neurotransmitter Agents (metabolism)
  • Norepinephrine (metabolism)
  • Serotonin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: